Optimer Pharmaceuticals ( OPTR)

This is a biopharmaceutical company focused on discovering, developing and commercializing anti-infective products. This stock is trading up 6.3% to $9.90 in recent trading.

Today's Range: $9.39-$10.03

52-Week Range: $8.79-$16.49

Volume: 336,000

Three-Month Average Volume: 557,752

From a technical perspective, OPTR is bouncing higher here off oversold levels with decent volume. This stock has been downtrending badly for the past three months, with shares plunging from a high of $16.49 to a recent low of $8.79. During that downtrend, shares of OPTR have been consistently making lower highs and lower lows, which is bearish technical price action. That said, the stock has now started to bounce off extremely oversold levels, since its relative strength index (RSI) reading was below 30 the past few weeks. That bounce is now pushing OPTR within range of triggering a near-term breakout trade. That trade will hit once OPTR manages to take out some near-term overhead resistance at $10.15 with high volume.

Traders should now look for long-biased trades in OPTR as long as it's trending above today's low of $9.37, and then once it sustains a move or close above $10.15 with volume that hits near or above 557,752 shares. If that breakout triggers soon, then OPTR will set up to bounce back towards its 50-day moving average of $11.73.

AEterna Zentaris ( AEZS)

This is a global biopharmaceutical company, which is focused on endocrine therapy and oncology with expertise in drug discovery, development and commercialization, mainly targeting the North American and European markets. This stock is trading up 8% to $2.15 in recent trading.

Today's Range: $1.90-$2.20

52-Week Range: $1.75-$13.02

Volume: 857,000

Three-Month Average Volume: 570,360

From a technical perspective, AEZS is trending higher here with above-average volume. This bounce today is coming after shares of AEZS recently downtrended badly from a high of $5.62 to a recent low of $1.75. During that downtrend, shares of AEZS were consistently making lower highs and lower lows, which is bearish technical price action. That said, this bounce is now pushing AEZS within range of triggering a near-term breakout trade. That trade will hit once AEZS manages to clear some near-term overhead resistance levels at $2.37 to $2.50 with high volume.

If you liked this article you might like

Biotech Movers: BioCryst, Omeros, Radius Health

Biotech Movers: Loxo, NewLink, BioCryst

Biotech Movers: Positive Phase Three Results For Roclatan Send Aerie Shares Soaring

Biotech Premarket Movers: Esperion, Minerva and BioCryst

Wait for the Pullback on BioCryst Pharmaceuticals

Wait for the Pullback on BioCryst Pharmaceuticals